Dimensional Fund Advisors
MRNA icon

Dimensional Fund Advisors’s Moderna MRNA Stock Holding History

Dimensional Fund Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$404M Sell
2,094,379
-374,396
-15% -$40.3M 0.07% 260
2026
Q2 		$173M Buy
2,468,775
+336,608
+16% +$17.4M 0.03% 765
2026
Q1 		$108M Buy
2,132,167
+343,216
+19% +$16M 0.02% 1011
2025
Q4 		$52.8M Buy
1,788,951
+987,312
+123% +$26.8M 0.01% 1484
2025
Q3 		$20.7M Sell
801,639
-307,828
-28% -$8.59M ﹤0.01% 1977
2025
Q2 		$30.6M Sell
1,109,467
-421,563
-28% -$11.1M 0.01% 1773
2025
Q1 		$43.5M Sell
1,531,030
-138,257
-8% -$4.91M 0.01% 1545
2024
Q4 		$69.3M Sell
1,669,287
-156,747
-9% -$7.49M 0.02% 1316
2024
Q3 		$122M Buy
1,826,034
+398,734
+28% +$36.6M 0.03% 861
2024
Q2 		$170M Buy
1,427,300
+29,566
+2% +$3.74M 0.04% 539
2024
Q1 		$149M Buy
1,397,734
+90,570
+7% +$9.13M 0.04% 639
2023
Q4 		$130M Sell
1,307,164
-530,849
-29% -$44.6M 0.04% 687
2023
Q3 		$190M Sell
1,838,013
-379,503
-17% -$42.3M 0.06% 354
2023
Q2 		$269M Sell
2,217,516
-342,438
-13% -$45.7M 0.09% 223
2023
Q1 		$393M Buy
+2,559,954
New +$422M 0.13% 119
2022
Q3 		$249M Buy
2,105,551
+847,329
+67% +$129M 0.1% 202
2022
Q2 		$180M Buy
1,258,222
+270,744
+27% +$38.7M 0.06% 346
2022
Q1 		$170M Buy
987,478
+47,755
+5% +$8.04M 0.05% 446
2021
Q4 		$239M Buy
939,723
+315,282
+50% +$92.2M 0.07% 284
2021
Q3 		$240M Buy
624,441
+337,553
+118% +$124M 0.08% 256
2021
Q2 		$67.4M Buy
286,888
+777
+0.3% +$139K 0.02% 1185
2021
Q1 		$37.4M Sell
286,111
-50,433
-15% -$7.31M 0.01% 1655
2020
Q4 		$35.2M Buy
336,544
+74,027
+28% +$7.49M 0.01% 1652
2020
Q3 		$18.6M Buy
262,517
+17,181
+7% +$1.2M 0.01% 1894
2020
Q2 		$15.8M Buy
245,336
+197,679
+415% +$10.8M 0.01% 1987
2020
Q1 		$1.43M Buy
47,657
+14,201
+42% +$327K ﹤0.01% 2810
2019
Q4 		$654K Buy
33,456
+1,501
+5% +$26.6K ﹤0.01% 3092
2019
Q3 		$509K Buy
+31,955
New +$472K ﹤0.01% 3135

Other funds holding MRNA

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Dimensional Fund Advisors's MRNA Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its Moderna (MRNA) stake by 15% in Q3 2026, selling an estimated $40.3M and leaving 2,094,379 shares worth $404M. The position accounts for 0.07% of the portfolio, ranked #260.

Dimensional Fund Advisors first reported a position in MRNA in Q3 2019 and has held it in 28 quarters since. 454 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Dimensional Fund Advisors held 2,094,379 shares of Moderna worth $404M as of Q3 2026.
  • Dimensional Fund Advisors sold 374,396 Moderna shares in Q3 2026, an estimated $40.3M.
  • Moderna made up 0.07% of Dimensional Fund Advisors's portfolio in Q3 2026, its #260 holding.
  • Dimensional Fund Advisors first reported a position in Moderna in Q3 2019 and has held it in 28 quarters since.
  • 454 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.